ArticleNanomaterials (Basel, Switzerland)2020
Extracellular Synthesis and Characterization of Silver Nanoparticles-Antibacterial Activity against Multidrug-Resistant Bacterial Strains.
Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Greener synthesis of silver nanoparticles fromFrontiers in cellular and infection microbiology · 2026Article
- Silver nanoparticles fabricated using phycocyanin from Arthrospira platensis: green synthesis, physicochemical characterization, and biological activities.Microbial cell factories · 2025Article
- Anti-Rickettsial Activity of Chitosan, Selenium, and Silver Nanoparticles: Efficacy in Vero Cells.Pathogens (Basel, Switzerland) · 2025Article
- Mitomycin C-immobilized silver nanoparticle-loaded polycaprolactone membrane for temporary scalp expansion after decompressive craniectomy to prevent wound infection.Bioengineering & translational medicine · 2025Article
- Article
- Silver Nanoparticles: A Comprehensive Review of Synthesis Methods and Chemical and Physical Properties.Nanomaterials (Basel, Switzerland) · 2024Review
- Extracellular synthesis of silver nanoparticle using yeast extracts: antibacterial and seed priming applicationss.Applied microbiology and biotechnology · 2024Article
- Article
- Hybrid Nanosystems of Antibiotics with Metal Nanoparticles-Novel Antibacterial Agents.Molecules (Basel, Switzerland) · 2023Review
- Applications of Gold and Silver Nanoparticles in Theranostics.Applied biochemistry and biotechnology · 2022Review
- Influence of Polyvinylpyrrolidone Concentration on Properties and Anti-Bacterial Activity of Green Synthesized Silver Nanoparticles.Micromachines · 2022Article
- Novel Biogenic Synthesis of a Ag@Biochar Nanocomposite as an Antimicrobial Agent and Photocatalyst for Methylene Blue Degradation.ACS omega · 2022Article
- Bacterial Mediated Rapid and Facile Synthesis of Silver Nanoparticles and Their Antimicrobial Efficacy against Pathogenic Microorganisms.Materials (Basel, Switzerland) · 2021Article
- Transformation of Biowaste for Medical Applications: Incorporation of Biologically Derived Silver Nanoparticles as Antimicrobial Coating.Antibiotics (Basel, Switzerland) · 2021Review
- Silicon-Based Ag Dendritic Nanoforests for Light-Assisted Bacterial Inhibition.Nanomaterials (Basel, Switzerland) · 2020Article
- Boosting nanotoxicity to combat multidrug-resistant bacteria in pathophysiological environments.Nanoscale advances · 2020Article
- Nanomaterials in Cosmetics: Recent Updates.Nanomaterials (Basel, Switzerland) · 2020Review
- Biosynthesis of Silver Nanoparticles Using Culture Supernatant ofInternational journal of nanomedicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Herein, we report the use of a cell-free extract for the extracellular synthesis of silver nanoparticles (AgNPs) and their potential to address the growing threat of multidrug-resistant (MDR) pathogenic bacteria. The reproducibility of AgNP synthesis was good and AgNP formation kinetics were monitored as a function of various reaction factors via ultraviolet-visible absorption spectroscopy. This green method was dependent on the alkaline pH of the reaction mixture. With the addition of dilute sodium hydroxide, well-dispersed AgNPs could be produced in large quantities via the classical nucleation and growth route. The new biosynthetic route enabled the production of AgNPs within a narrow size range of 4 to 17 nm. The AgNPs were characterized using various techniques and their antibacterial activity against MDR pathogenic bacteria was evaluated. Field-emission scanning electron microscopic imaging revealed prominent morphological changes in Staphylococcus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.